MedTrace Logo

Antismoking Effects of Electronic Cigarettes in Subjects With Schizophrenia and Their Potential Influence on Cognitive Functioning.

NCT01979796 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2026-05-14

No results posted yet for this study

Summary

It is well established in studies across several countries that tobacco smoking is more prevalent among schizophrenic patients than the general population. Electronic cigarettes (e-cigarettes) are becoming increasingly popular with smokers worldwide. To date there are no large randomised trials of e-cigarettes in schizophrenic smokers. A well-designed trial is needed to compare efficacy and safety of these products in this special population.

Conditions

  • Tobacco Smoking in Schizophrenic Patients

Interventions

DEVICE

Ecig 24 mg nicotine

Cigalike

DEVICE

Ecig 0 mg nicotine

Cigalike

DEVICE

Nicotine free inhalator

Plastic CIG a Like

Sponsors & Collaborators

  • Universita degli Studi di Catania

    lead OTHER

Principal Investigators

  • Pasquale Caponnetto, Assis Prof · University of Catania

  • Eugenio Aguglia, Professor · University of Catania

  • Giuseppe Minutolo, Assis prof · University of Catania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-31
Primary Completion
2023-12-31
Completion
2024-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01979796 on ClinicalTrials.gov